Text size
Novavax labs in Gaithersburg, Md.
Andrew Caballero-Reynolds/AFP via Getty Images
Novavax
shares were plunging more than 15% Tuesday after the company acknowledged to Reuters that it has completed delivery of only about 10 million doses of its Covid-19 vaccine—far fewer than expected.
Novavax
(ticker: NVAX) said as recently as last month that it had committed to…
